9-136757914-C-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000371688.8(LCN8):c.17G>T(p.Arg6Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,461,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R6Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000371688.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN8 | NM_178469.4 | c.17G>T | p.Arg6Leu | missense_variant | 1/7 | ENST00000371688.8 | NP_848564.2 | |
LCN8 | NM_001345934.2 | c.93+537G>T | intron_variant | NP_001332863.1 | ||||
LCN8 | XM_017014272.3 | c.93+537G>T | intron_variant | XP_016869761.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN8 | ENST00000371688.8 | c.17G>T | p.Arg6Leu | missense_variant | 1/7 | 1 | NM_178469.4 | ENSP00000360753 | P2 | |
LCN8 | ENST00000612714.1 | c.93+537G>T | intron_variant | 1 | ENSP00000482512 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248136Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134648
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461426Hom.: 0 Cov.: 40 AF XY: 0.0000316 AC XY: 23AN XY: 727018
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at